These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 15960169

  • 1. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A, Hayashi S, Noguchi M.
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S, Watanabe N, Kojima S, Kagawa T, Mine T, Myojin K, Koizumi J.
    Tokai J Exp Clin Med; 2007 Jul 20; 32(2):70-4. PubMed ID: 21319062
    [Abstract] [Full Text] [Related]

  • 3. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H, Toyota N, Hieda M, Ishikawa M, Tanitame K, Tani C, Okazaki A, Takaki S, Aikata H, Chayama K, Awai K.
    Hiroshima J Med Sci; 2011 Mar 20; 60(1):15-9. PubMed ID: 21675043
    [Abstract] [Full Text] [Related]

  • 4. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis.
    Tanaka O, Ishihara K, Oyamada H, Harusato A, Yamaguchi T, Ozawa M, Nakano K, Yamagami T, Nishimura T.
    J Vasc Interv Radiol; 2006 Dec 20; 17(12):1951-5. PubMed ID: 17185692
    [Abstract] [Full Text] [Related]

  • 5. [A case of portal-systemic shunt-through inferior mesenteric vein and right internal iliac vein-encephalopathy cured by balloon-occluded retrograde transvenous obliteration].
    Shimizu K, Nakashima M, Fujimoto M, Tsuruta S, Morita S, Furukawa R, Mori M.
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec 20; 106(12):1764-9. PubMed ID: 19966519
    [Abstract] [Full Text] [Related]

  • 6. Hepatic encephalopathy from dual splenorenal shunts treated with balloon-occluded retrograde transvenous obliteration by using a double-balloon technique.
    Matake K, Tajima T, Yoshimitsu K, Irie H, Aibe H, Nishie A, Asayama Y, Honda H.
    J Vasc Interv Radiol; 2007 Nov 20; 18(11):1436-40. PubMed ID: 18003996
    [Abstract] [Full Text] [Related]

  • 7. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K, Yamasaki K, Ichikawa T, Takeshima F, Nakao K.
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct 20; 108(10):1726-34. PubMed ID: 21971147
    [Abstract] [Full Text] [Related]

  • 8. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M, Toyonaga A, Inoue H, Miyakoda K, Morita Y, Emori K, Sakamoto Y, Oho K, Sata M.
    J Gastroenterol Hepatol; 2010 Jun 20; 25(6):1129-35. PubMed ID: 20594229
    [Abstract] [Full Text] [Related]

  • 9. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K.
    J Vasc Interv Radiol; 2007 Jan 20; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [Abstract] [Full Text] [Related]

  • 10. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration.
    Kawanaka H, Ohta M, Hashizume M, Tomikawa M, Higashi H, Kishihara F, Sugimachi K, Tokumatsu M.
    Am J Gastroenterol; 1995 Mar 20; 90(3):508-10. PubMed ID: 7872302
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H.
    Intern Med; 2001 Aug 20; 40(8):688-91. PubMed ID: 11518103
    [Abstract] [Full Text] [Related]

  • 12. Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt.
    Numata K, Tanaka K, Kiba T, Saito S, Shirato K, Kitamura T, Sekihara H.
    J Gastroenterol; 1998 Jun 20; 33(3):424-7. PubMed ID: 9658325
    [Abstract] [Full Text] [Related]

  • 13. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension].
    Hirota S, Fukuda T, Matsumoto S, Sugimoto K, Isaki K, Yoshikawa T, Akasaka Y, Sugimura K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun 20; 60(7):361-7. PubMed ID: 10921294
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report.
    Furue Y, Hidaka H, Fujii K, Matsunaga K, Koizumi W.
    J Med Case Rep; 2015 Mar 20; 9():62. PubMed ID: 25886049
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hepatic encephalopathy due to inferior mesenteric vein/inferior vena cava and gonadal vein shunt using dual balloon-occluded retrograde transvenous obliteration.
    Tanaka R, Ibukuro K, Abe S, Tobe K, Fukuda H, Kondou Y, Tagawa K.
    Cardiovasc Intervent Radiol; 2009 Mar 20; 32(2):390-3. PubMed ID: 18839245
    [No Abstract] [Full Text] [Related]

  • 16. Chronic portal-systemic shunt encephalopathy in a hemodialysis patient treated with balloon-occluded retrograde transvenous obliteration.
    Yasukawa R, Akiyama F, Tsukishiro T, Narita I.
    Case Rep Nephrol Urol; 2013 Jan 20; 3(1):28-33. PubMed ID: 23626595
    [Abstract] [Full Text] [Related]

  • 17. [A case of portal-systemic encephalopathy with slowly progressive, non-flapping tremor].
    Oue Y, Sakata C, Sudoh S, Kurokawa K, Nakamura S.
    Rinsho Shinkeigaku; 1995 Aug 20; 35(8):889-92. PubMed ID: 8665732
    [Abstract] [Full Text] [Related]

  • 18. Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt.
    Rogal SS, Hu A, Bandi R, Shaikh O.
    World J Gastroenterol; 2014 Jul 07; 20(25):8288-91. PubMed ID: 25009405
    [Abstract] [Full Text] [Related]

  • 19. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H, Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Mitsuyama K, Tsuruta O, Sata M.
    Kurume Med J; 2014 Jul 07; 61(1-2):1-8. PubMed ID: 25420513
    [Abstract] [Full Text] [Related]

  • 20. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A, Chalamarla LK, Singla N, Shasthry SM, Sarin SK.
    Eur Radiol; 2020 Jun 07; 30(6):3462-3472. PubMed ID: 32048037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.